The U.S. cell and gene therapy market is currently experiencing a massive wave of capital investment and infrastructure expansion. As the industry shifts from early-stage research to large-scale commercialization, major pharmaceutical and biotechnology companies are solidifying their presence by building state-of-the-art manufacturing facilities, acquiring specialized innovators, and forging...